Learn about Amplatzer Piccolo Occluder

A NEW LEVEL OF VERSATILITY AND PROVEN SAFETY FOR THE YOUNGEST INFANTS AND UP.

LEARN ABOUT AMPLATZER PICCOLO™ OCCLUDER

THE BROADEST PORTFOLIO, MOST COMPREHENSIVE SIZE RANGE, DESIGNED SPECIFICALLY FOR EACH CONDITION

Avoid the need to perform heart surgery—and help facilitate faster recovery and lower complications rates—with minimally invasive, transcatheter closure solutions.

BAO’S STORY

Thanks to innovative research, manufacturing and some special help from her mother, the Amplatzer™ Septal Occluder has made a huge difference in Bao’s life, giving her the ability to be there for her family.

CONGENITAL HEART DEFECTS

ATRIAL SEPTAL DEFECTS (ASD)

An atrial septal defect (ASD) is a hole in the septum between the atria. ASDs are one of the most common congenital heart defects seen in pediatric cardiology and often occur in conjunction with other cardiac defects.1,2

LEARN MORE ABOUT OUR ASD TREATMENT OPTIONS

PATENT DUCTUS ARTERIOSUS (PDA)

Patent ductus arteriosus (PDA) happens when the ductus arteriosus, the arterial shunt in fetal life, fails to close after birth. The ductus arteriosus typically closes shortly after birth, creating the flow of blood directly from the heart to the lungs. If the ductus arteriosus doesn’t close, it creates a reverse blood flow from the aorta into the pulmonary artery and is then recirculated through the lungs. A medium to large PDA may require closure to avoid serious complications.

LEARN MORE ABOUT OUR PDA TREATMENT OPTIONS

MEET OUR NEW OCCLUDER

VENTRICULAR SEPTAL DEFECTS (VSD)

A ventricular septal defect is hole in the septum between the ventricles and is the most common type of heart malformation. A VSD allows blood from the left ventricle to pass through into the right ventricle, creating extra stress to the right ventricle in order to keep up with the additional blood flow. Patients with a VSD carry an increased risk of infection to the heart walls and valves.

LEARN MORE ABOUT OUR VSD TREATMENT OPTIONS

REFERENCES

1. Moake, L., & Ramaciotti, C., Atrial Septal Defect Treatment Options (2005). AACN Clinical Issues, 16(2), 252-266.
2. McMahon, C. J., Feltes, T. F., Fraley, J. K., Bricker, J. T., Grifka, R. G., Tortoriello, T. A.,…Bezold, L. I. (2002). Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart, 87(3), 256-259.